Moleculin Biotech Inc Stock (MBRX) Forecast
The Moleculin Biotech Inc (MBRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2,545.98, representing a +28,864% increase from the current price of $8.79. The highest analyst price target is $2,177.11, and the lowest is $2,914.85.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MBRX Price Target
Average 4,988.18 (+56,648% Upside)
Is Moleculin Biotech Inc (MBRX) A Buy Now?
Oscillators
Buy: 1 · Sell: 1 · Neutral: 5Summary: Neutral
Moving Averages
Buy: 4 · Sell: 6 · Neutral: 0Summary: Sell
According to our latest analysis, MBRX could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on MBRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 49.66 indicates that MBRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 57.42 indicates that MBRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 92.65 indicates that MBRX is overbought. This suggests that MBRX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of 18.39 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of 55.72 indicates that MBRX is still overbought but not to an extreme extent.
Long-term MBRX price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Moleculin Biotech Inc financial reports and earnings history, Moleculin Biotech Inc (MBRX) stock could reach $6,803.41 by 2030, $32,810.97 by 2040 and $72,432.05 by 2050. See the projected annual prices until 2050 of the Moleculin Biotech Inc stock below:
- Moleculin Biotech Inc (MBRX) is expected to reach an average price of $12,881.11 in 2035, with a high prediction of $16,494.86 and a low estimate of $12,966.11. This indicates an +146.44K% change from the last recorded price of $8.79.
- Moleculin Biotech Inc (MBRX) stock is projected to chart a bullish course in 2040, with an average price target of $25,183.39, representing an +286.40K% change from its current level. The forecast ranges from a conservative $24,878.30 to a sky-high $32,810.97.
- Our analysts predict Moleculin Biotech Inc (MBRX) to change +477.23K% by 2045, soaring from $42,662.76 to an average price of $41,957.01, potentially reaching $47,775.50. While $42,662.76 is the low estimate, the potential upside is significant.
- Moleculin Biotech Inc (MBRX) stock is expected to climb by 2050, reaching an average of $58,725.06, a +667.99K% change from its current level. However, a wide range of estimates exists, with high and low targets of $72,432.05 and $59,014.56, respectively, highlighting the market's uncertainty.
Moleculin Biotech Inc Stock (MBRX) Year by Year Forecast
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2026
The predicted value for Moleculin Biotech Inc (MBRX) in 2026 is set at an average of $503.01. Estimates vary from a peak of $2,177.11 to a trough of $3.23, indicating an +5,623% surge from the present price of $8.79.
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Moleculin Biotech Inc (MBRX) is $5,373.17, with a high forecast of $7,516.74 and a low forecast of $3,206.30. This indicates an +61,028% increase from the last price of $8.79.
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2028
In 2028, Moleculin Biotech Inc (MBRX) is projected to reach an average price of $6,648.16, with a high projection of $8,327.41 and a low estimate of $4,610.49. This indicates an +75,533% rise from the last price of $8.79.
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2029
The 2029 price forecast for Moleculin Biotech Inc Stock (MBRX) is $6,504.98 on average, with a high prediction of $8,189.68 and a low estimate of $5,052.13. This represents an +73,904% increase from the previous price of $8.79.
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2030
Moleculin Biotech Inc Stock (MBRX) is expected to reach an average price of $5,700.14 in 2030, with a high forecast of $6,803.41 and a low forecast of $4,819.43. This signifies an +64,748% surge from the last price of $8.79.
